See today's BioWorld Science
To read the full story, subscribe or sign in.
Endocrine/Metabolic

FDA clears allogenic cellular therapy Allostem to enter clinic for type 1 diabetes

Nov. 4, 2022
Creative Medical Technology Holdings Inc. has received FDA clearance of its IND application for a clinical trial of Allostem in type 1 diabetes.
BioWorld Science Cell therapy Endocrine/metabolic Cell therapy FDA IND